Merck has announced the launch of a new state-of-the-art M Lab Collaboration Centre in the Songdo district of Incheon in South Korea.

The centre is one of nine worldwide and is intended to provide biopharmaceutical manufacturers with a shared, exploratory environment where they can collaborate with Merck scientists and engineers to solve problems and develop new therapies.

“Merck has opened a new M Lab Collaboration Centre in the Songdo district of Incheon in South Korea.“

It replaces a smaller facility in Seoul and offers a simulated manufacturing environment providing full end-to-end process development support, plus education on the best ways to develop, optimise and scale up processes and simplify global technology transfers.

The site spans 1,865 sq m and will house more than ten highly-trained scientists and engineers, and will host collaborations with companies ranging from multinational organisations like Samsung Biologics to smaller emerging businesses.

Udit Batra, member of the Merck executive board and chief executive officer for life sciences, said: "With a rapidly growing biopharmaceutical industry in Korea and demand for novel and cost-effective therapies worldwide, there is a clear need for innovative concepts like our M Lab Collaboration Centres."

Songdo is rapidly emerging as the world's largest biologics manufacturing hub, with 520 KL of plant capacity by 2018.

With over 20 years of experience within the science market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current science roles we have available, you can search for the latest job roles, register your details, or contact the team today.